Top of the morning to you. And a fine one it is here on the Pharmalot campus, where the short person has left for the local schoolhouse and we are planning another busy day. In fact, our posting schedule will be quite light as we depart for an interesting event. Nonetheless, we will continue to forage for interesting items. So please keep us in mind if you hear of anything fascinating. Meanwhile, we hope you have a productive day …
Drug makers are boosting sales in India through screening programs billed as corporate social responsibility, BMJ reports. At “health camps” across the country, drug reps and technicians have tested millions of Indians for chronic diseases, with doctors prescribing their products in return. These testing services have raised concerns about the impact on public health and prompted questions about violating national regulations.
Prescription drug spending in the US grew rapidly last year, reaching 12.2 percent compared with 2.4 percent in 2013, partly due to costly new treatments for hepatitis C, cancer, and multiple sclerosis, according to new government statistics published in Health Affairs. Overall, US health care spending increased 5.3 percent to $3 trillion in 2014. The added spending was largely due to coverage expansion attributed to the Affordable Care Act.
About the Author Reprints
